1-3 of 3
Kantarjian Hagop, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Factors for Outcome in Patients (pts) with Refractory and Relapsed Acute Lymphocytic Leukemia (ALL) Treated with Inotuzumab Ozogamicin (IO), a CD22 Monoclonal Antibody

Elias Jabbour, MD, Susan O'Brien, MD, Koji Sasaki, Xuelin Huang, PhD, Deborah A. Thomas, MD, Michael E. Rytting, MD, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD, Pierce Sherry, RN, Tapan M. Kadia, MD, Kantarjian Hagop, MD
Journal: Blood
Blood (2014) 124 (21): 2288.
https://doi.org/10.1182/blood.V124.21.2288.2288
Published: 2014
Journal Articles

Phase II Study Of The Hyper-CVAD Regimen In Combination With Ofatumumab As Frontline Therapy For Adults With CD-20 Positive Acute Lymphoblastic Leukemia (ALL)

Elias Jabbour, MD, Kantarjian Hagop, MD, Deborah Thomas, MD, Guillermo Garcia-Manero, MD, Daniela Hoehn, MD, PhD, Rebecca Garris, BSc, Stefan H. Faderl, MD, Jorge E. Cortes, MD, Tapan M. Kadia, MD, Farhad Ravandi, MD, Srdan Verstovsek, MD, PhD, Susan O'Brien, MD
Journal: Blood
Blood (2013) 122 (21): 2664.
https://doi.org/10.1182/blood.V122.21.2664.2664
Published: 2013
Journal Articles

Incidence Of and Risk Factors For Acute Myeloid Leukemia Involvement Of The Central Nervous System

Rozovski Uri, MD, Maro Ohanian, DO, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Stefan H. Faderl, MD, Jorge E. Cortes, MD, Sherry R. Pierce, RN, BS, Kantarjian Hagop, MD, Zeev Estrov, MD
Journal: Blood
Blood (2013) 122 (21): 3883.
https://doi.org/10.1182/blood.V122.21.3883.3883
Published: 2013